Medical emergency? Call 911.Call Poison Control

Prescription Rules in District of Columbia

Location

State: District of Columbia

Capital: Washington, D.C.

Coordinates: 38.9072, -77.0369

Controlled-substance scheduling is federal, so the schedule for each medication is the same in District of Columbia as everywhere else. This page covers what is specific to District of Columbia: pharmacy licensing, its prescription drug monitoring program, and the general telehealth posture for controlled substances.

Important

This site provides educational information only and does not sell, prescribe or dispense medications. Always consult a licensed healthcare provider. This page is not medical advice.

Pharmacy board

The District of Columbia board of pharmacy is the body that licenses pharmacies and pharmacists operating here. A seller that is not licensed in District of Columbia is not operating lawfully here, regardless of what its website says.

Visit the District of Columbia board of pharmacy →

Prescription drug monitoring program

https://dchealth.dc.gov/

Telehealth prescribing

In broad terms, District of Columbia allows some remote prescribing, subject to registration, follow-up, and in-person requirements. Federal rules still apply on top of this, including the requirement that a practitioner have a bona fide clinician-patient relationship and that controlled substances generally be prescribed only in person, subject to limited exceptions.

What does not change in District of Columbia

  • Whether a medication is Schedule I, II, III, IV, or V. That is federal law.
  • Whether a medication requires a valid prescription.
  • That buying a controlled medication without a prescription is a federal crime, not just a state one.

Last reviewed October 2026.

Editorial Review Board

Clinical review by licensed pharmacists (PharmD)

Every page on this site is reviewed against current FDA prescribing information, DailyMed labelling, DEA scheduling regulations and MedlinePlus monographs before publication. Reviewers have no commercial relationship with any manufacturer or pharmacy.

Last substantive review: October 01, 2026